The tech giant Oracle requested to change the zoning for land on the East Bank of the Cumberland River last week, giving a ...

Mark Field joins the DNA sequencing giant after six years at Insulet, which makes devices for people with diabetes.

Which had the better earnings? Cava: Is there enough tasty growth to support a spicy valuation? To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center .